Sodium glucose co-transporter 2 inhibitors in patients with resistant hypertension: a case study.
Sodium glucose co-transporter 2 inhibitors lower blood pressure by osmotic diuresis and can be considered in diabetic patients with resistant hypertension.
Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
Amira
A
Obeid
Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
Mark
M
Pucci
Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
Una
U
Martin
Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
Wasim
W
Hanif
SGLT2 inhibitor; canagliflozin; diabetes; obesity; resistant hypertension
BMC Endocr Disord. 2014 Apr 18;14:37
24742013
J Am Soc Hypertens. 2014 May;8(5):330-9
24631482
Nat Rev Endocrinol. 2014 Jun;10(6):364-76
24732974
J Am Soc Hypertens. 2014 Apr;8(4):262-75.e9
24602971
BMJ. 2012 Nov 20;345:e7473
23169802
Am J Physiol Renal Physiol. 2004 Jan;286(1):F127-33
14506074
N Engl J Med. 2015 Nov 26;373(22):2117-28
26378978
Clin Ther. 2015 Jun 1;37(6):1150-66
25891804